Publication of Information Document for Admission on Euronext Growth Oslo Read more about Publication of Information Document for Admission on Euronext Growth Oslo
Van Lanschot Kempen to return capital of €1.50 per share on 22 December 2022 Read more about Van Lanschot Kempen to return capital of €1.50 per share on 22 December 2022
Hynion AS: Final Result of the Rights Issue Read more about Hynion AS: Final Result of the Rights Issue
Norsk Hydro: Capital Markets Day 2022 - Unique position in a new reality Read more about Norsk Hydro: Capital Markets Day 2022 - Unique position in a new reality
GenSight Biologics Announces Publication of Indirect Comparison of LUMEVOQ® Versus Natural History in ND4-LHON Patients in Peer-Reviewed Journal Ophthalmology and Therapy Read more about GenSight Biologics Announces Publication of Indirect Comparison of LUMEVOQ® Versus Natural History in ND4-LHON Patients in Peer-Reviewed Journal Ophthalmology and Therapy
Gaming Innovation Group acquires AskGamblers Read more about Gaming Innovation Group acquires AskGamblers
bioMérieux – Increased outlook for full-year 2022 and 2023 guidance preview Read more about bioMérieux – Increased outlook for full-year 2022 and 2023 guidance preview
Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer Read more about Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer